Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/30/2003WO2003040310A3 Novel epidermal growth factor protein and gene, and methods of use therefor
10/30/2003WO2003035693A3 Crystals of cytochrome p450 2c9, structures thereof and their use
10/30/2003WO2003034903A3 Psma antibodies and protein multimers
10/30/2003WO2003033703A3 Human gtp-activator protein for rab-like gtpase
10/30/2003WO2003031612A3 Method for determining cell cycle position
10/30/2003WO2003031588A3 Hepatitis c virus vaccine
10/30/2003WO2003031568A3 Intracellular signaling molecules
10/30/2003WO2003027143A3 Gene and protein relating to hepatocellular carcinoma
10/30/2003WO2003016549A3 Nucleic-acid associated proteins
10/30/2003WO2003010333A3 Methods for gene disruption and uses thereof
10/30/2003WO2003010312A3 Nucleic acid sequences encoding enantioselective amidases
10/30/2003WO2003008618A3 Glucans and glucansucrases derived from lactic acid bacteria
10/30/2003WO2003008615A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced succ or sucd gene
10/30/2003WO2003008608A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced phoe gene
10/30/2003WO2003008605A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced male gene
10/30/2003WO2003008593A3 A thermostable isomerase and use thereof in particular for producing tagatose
10/30/2003WO2003002728A3 Prevention of retrogradation of starch
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2003000051A3 Novel biofungicide
10/30/2003WO2002100530A3 Method for controlling fermentation
10/30/2003WO2002094876A3 Methods and compositions for treating respiratory mucin production associated disease conditions
10/30/2003WO2002094851A3 Peptide vaccines against group a streptococci
10/30/2003WO2002093519A3 Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus
10/30/2003WO2002083945A3 Diagnosis and treatment of cancer: i
10/30/2003WO2002074943A3 Nucleic acid molecules coding for a dextran-saccharase catalysing the synthesis of dextran with alpha 1,2-osidic sidechains
10/30/2003WO2002072848A3 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
10/30/2003WO2002072758A3 Cytochrome p450s and uses thereof
10/30/2003WO2002068645A3 Compositions and methods relating to breast specific genes and proteins
10/30/2003WO2002068617A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/30/2003WO2002066612A3 Novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system
10/30/2003WO2002064784A3 Yeast strain of saccharomyces cerevisiae with functional expression of a glut transporter
10/30/2003WO2002060276A8 Combination of probiotics
10/30/2003WO2002059327A3 Sulfatases and methods of use thereof
10/30/2003WO2002059283A3 Nucleic acid modification enzymes
10/30/2003WO2002057476A3 Methods and microorganisms for the production of 3-(2-hydroxy-3-methyl-butyrylamino)-propionic acid (hmbpa)
10/30/2003WO2002044361A8 Eukaryotic expression libraries based on double lox recombination and methods of use
10/30/2003WO2002034783A3 Transmembrane proteins
10/30/2003US20030204871 Method for the production of calendic acid, a fatty acid containing delta-8,10,12 conjugated double bonds and related fatty acids having a modification at the delta-9 position
10/30/2003US20030204868 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/30/2003US20030204867 Nucleotide sequences coding transport protein for generating transgenic crop plants with adjusted nitrogen metabolism and which grow on acidic soils; increased biomass production
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030204074 Streptococcus pneumoniae 37-kDa surface adhesin a protein
10/30/2003US20030204072 Comprises receptor protein tyrosine kinase (rPTK) for diagnosing and treating kidney or neurodegenerative diseases
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204068 Nucleotide sequences coding campylobacter proteins for use in preventing bacterial, fungal and viral infection as well as treat gastrointestinal disorders and peptic ulcers; genetic vaccines
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203474 Method of facilitating mass production and sporulation of arbuscular mycorrhizal fungi aseptic in vitro
10/30/2003US20030203472 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
10/30/2003US20030203468 Preparation of acariogenic sugar substitutes
10/30/2003US20030203467 Novel variant EGIII-like cellulase compositions
10/30/2003US20030203466 Comprises hydrolase for treating textiles, degrading plant biomass and fracturing subterranean formations
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203459 Method for the production of D-(-)-3-hydroxybutyric acid by recombinant esherichia coli
10/30/2003US20030203456 Microbial production of epoxides
10/30/2003US20030203455 Heat-stable D-aminoacylase
10/30/2003US20030203454 Methods for producing end-products from carbon substrates
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203449 Novel 2,5-diketo-L-gluconic acid reductases and methods of use
10/30/2003US20030203447 Methods and materials for increasing expression of recombinant polypeptides
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders
10/30/2003US20030203398 Ribosomal DNA sequence for detection of activated sludge bacterial strain; biodegradation; bioremediation
10/30/2003US20030203396 Human galactosyltransferases
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202985 Methods and compositions for immunotherapy of cancer
10/30/2003US20030202983 Protein for medical diagnosis; preventing infections; genetic engineering
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003CA2830864A1 Methods of creating modified promoters resulting in varying levels of gene expression
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483474A1 Lewis y epitope modified polypeptide, or mucin fusion polypetide, tumor vaccines
10/30/2003CA2483338A1 Method of creating a library of bacterial clones with varying levels of gene expression
10/30/2003CA2482995A1 Low-cost production of peptides
10/30/2003CA2482485A1 Matrix analysis of gene expression in cells (magec)
10/30/2003CA2481986A1 Surface transfection and expression procedure
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2481507A1 Compositions and methods for the diagnosis and treatment of tumor
10/30/2003CA2481414A1 Promoter and plasmid system for genetic engineering
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003CA2481409A1 Thermostable dna polymerases and methods of making same
10/30/2003CA2481108A1 Tuberculosis vaccines including recombinant bcg strains expressing alanine dehydrogenase, serine dehydratase and/or glutamine synthetase
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/30/2003CA2478991A1 Compositions and methods for augmenting kidney function
10/30/2003CA2455898A1 Rapid sterilization and vaccine preparation
10/29/2003EP1357190A1 Methods and markers for simple transformation and selection of recombinant ciliates
10/29/2003EP1357189A2 Elicitor of the hypersensitive response in plants
10/29/2003EP1357187A1 Novel physiologically active peptide and use thereof
10/29/2003EP1357186A1 Novel proteins and dnas thereof
10/29/2003EP1357181A1 Novel atopic dermatitis-associated gene and proteins
10/29/2003EP1357179A1 Solid culture medium and method for preparing the same
10/29/2003EP1357128A1 The preparation and usage of plasmodium fusion antigen
10/29/2003EP1357126A1 Method of assaying lysophospholipase d activity
10/29/2003EP1356874A1 Organic waste fermentatively-processing device
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356102A2 Polymorphic sequences of the human abca1 gene, their uses, detection methods and kits
10/29/2003EP1356084A2 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples
10/29/2003EP1356073A2 Fermentation method for production of heterologous gene products in lactic acid bacteria
1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 1489